Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LENALIDOMIDA KRKA 25 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LENALIDOMIDA KRKA 25 MG CAPSULAS DURAS EFG

Approved

STANDARD

LENALIDOMIDA KRKA 25 MG CAPSULAS DURAS EFG

Krka D.D. Novo Mesto🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 19, 2021
Approval ID: cbdd2f6f877a3c7c
Company: Krka D.D. Novo Mesto
Type: Standard

Approval Details

Approval Id: cbdd2f6f877a3c7c
Drug Cima Aemps Name: LENALIDOMIDA KRKA 25 MG CAPSULAS DURAS EFG
Register Number: 1201519013
Holder Company Name: Krka D.D. Novo Mesto
Marketing Company Name: Krka Farmaceutica S.L.
Authorization Date: 2021-03-19
Dosage Form: CÁPSULA DURA
Dose: 25 mg
Route Of Administration: VÍA ORAL
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Krka D.D. Novo Mesto

Active Ingredients

LENALIDOMIDA HIDROCLORURO HIDRATO

30,27 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 19, 2021

Approval ID

cbdd2f6f877a3c7c

Type

Standard

Back to CIMA-AEMPS Approvals